GoKawiilStudy identifies MLLT1 and MLLT3 as factors that focus AID onto specific gene loci
Researchers report that the histone-reader proteins MLLT1 and MLLT3 help concentrate the enzyme AID at particular genomic locations in B cells. This targeting mechanism appears to explain how AID achieves locus specificity during processes such as somatic hypermutation, rather than acting broadly across the genome.
GoKawiil's interpretation of the reporting above, not reported fact.
AID mutagenic activity is essential for antibody diversification but can also cause off-target DNA damage linked to B-cell lymphoma when misdirected to non-immunoglobulin genes. Understanding how MLLT1 and MLLT3 concentrate AID at specific loci could help explain why certain super-enhancers and oncogenes become hypermutated during lymphoma development, according to the broader body of research cited alongside this study. This mechanistic insight may eventually inform how researchers think about mutation hotspots in B-cell cancers.
- MLLT1 and MLLT3 act as histone readers that help concentrate AID at specific genomic loci
- This targeting mechanism may underlie AID's locus specificity during antibody diversification
- Findings could have implications for understanding off-target AID activity linked to B-cell lymphomagenesis
Source: nature.com — Seija, 2026-09-30
Published there as: “Histone readers MLLT1 and MLLT3 concentrate AID to confer locus specificity”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.